摘要
Background and Aims: The redefinition of metabolic-associated fatty liver disease (MAFLD) from nonalcoholic fatty liver disease (NAFLD) has caused a revolution in clinical practice, and the characteristics of patients with steatosis but not MAFLD remain unclear. The aims were to compare the diagnosis rate of MAFLD in NAFLD using different steatosis methods and explore the features of non-MAFLD-NAFLD and MAFLD-non-NAFLD. Methods: A cross-sectional study enrolling consecutive individuals was conducted at three medical centers in southern China from January 2015 to September 2020. Steatosis was evaluated by liver biopsy or magnetic resonance imaging-based proton density fat fraceter (CAP), and fatty liver index (FLI). Fibrosis was assessed by the NAFLD fibrosis score, transient elastography, or shear wave elastography. Results: The study enrolled 14,985 Chinese adults. The agreement of MAFLD and NAFLD diagnoses were 83% for FLI, 95% for ultrasound, 94% for both CAP and MRI-PDFF, and 95% for liver biopsy. The body mass index, blood pressure and lipid levels among non-MAFLD-NAFLD pa-tients were similar metabolic parameters (p>0.05 for all), but not the alanine aminotransferase and the proportion of pa-tients with insulin resistance, which were significantly higher in non-MAFLD-NAFLD with significant fibrosis. Conclusions: The new MAFLD definition ruled out 5-17% of NAFLD cases. NAFLD and MAFLD-NAFLD involved more severe metabolic abnormalities than MAFLD and MAFLD-non-NAFLD. Non-MAFLD-NAFLD patients with significant fibrosis had more se-vere liver injury and increased glycemic dysregulation within the normal range. Attention should be paid to its progression.
学科与关键词
- The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in ChinaYang, Rui-Xu; Zou, Zheng-Sheng; Zhong, Bi-Hui; Deng, Hong; He, Fang-Ping; Shi, Jun-Ping; Zhao, Cai-Yan; Mi, Yu-Qiang; Zhou, Yong-Jian; Di, Fu-Sheng; Zheng, Rui-Dan; Du, Qin; Shang, Jia; Popovic, Branko; Chen, JinJun*; Fan, Jian-Gao*Hepatobiliary & Pancreatic Diseases International, 2021, 20(5): 426-432.被引 9
- Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validationYe, Junzhao; Zhuang, Xiaodong; Li, Xin; Gong, Xiaorong; Sun, Yanhong; Wang, Wei; Feng, Shiting; Wu, Tingfeng*; Zhong, Bihui*Metabolism: Clinical and Experimental , 2022, 136: 155294.被引 10
- Metabolic Disorders Combined with Noninvasive Tests to Screen Advanced Fibrosis in Nonalcoholic Fatty Liver DiseaseShi, Yi-Wen; He, Fang-Ping; Chen, Jin-Jun; Deng, Hong; Shi, Jun-Ping; Zhao, Cai-Yan; Mi, Yu-Qiang; Zou, Zheng-Sheng; Zhou, Yong-Jian; Di, Fu-Sheng; Zheng, Rui-Dan; Du, Qin; Shang, Jia; Yang, Rui-Xu; Popovic, Branko; Zhong, Bi-Hui*; Fan, Jian-Gao*Journal of Clinical and Translational Hepatology, 2021, 9(5): 607-614.被引 4
